Charles Ellis Cohen

Title: Innovations of Charles Ellis Cohen in Immunological Intervention

Introduction

Charles Ellis Cohen is an accomplished inventor based in Indianapolis, IN (US). He has made significant contributions to the field of immunology through his innovative work on synthetic polysaccharide antigens. His research focuses on developing solutions for inflammatory pathologies, showcasing his commitment to advancing medical science.

Latest Patents

Cohen holds a patent for "Synthetic polysaccharide antigens for immunological intervention in disease." This patent describes synthetic polysaccharide antigens (SPAs) that possess either anti-inflammatory or inflammatory immunomodulatory properties, depending on their structure. The patent also outlines compositions that include these SPAs and methods for using them to prevent or treat diseases that are susceptible to inflammatory immunomodulators.

Career Highlights

Cohen is associated with Eli Lilly and Company, a leading pharmaceutical company known for its innovative research and development in healthcare. His work at Eli Lilly has allowed him to contribute to significant advancements in immunological therapies.

Collaborations

Cohen has collaborated with notable colleagues, including Larry C Blaszczak and John Astor Cleveland, Jr. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of immunology.

Conclusion

Charles Ellis Cohen's contributions to immunological intervention through his patent on synthetic polysaccharide antigens highlight his role as a key innovator in the medical field. His work continues to pave the way for advancements in treating inflammatory diseases.